ONYX PHARM INC ONXX (NASDAQ)

(NEW YORK)Onyx Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. said Thursday they are enrolling patients in a late stage trial of their drug Nexavar as a post-surgery treatmen...READ MORE

(NEW YORK)Partners Onyx Pharmaceuticals and Bayer said Monday China's drug regulatory agency approved the liver cancer treatment Nexavar, opening the door to one of the largest markets for t...READ MORE

(NEW YORK)Onyx Pharmaceuticals Inc. said Gregory W. Schafer has resigned as chief financial officer, effective Dec. 15 or earlier if the company finds a replacement.READ MORE

(NEW YORK)Sales of the cancer drug Nexavar will push Onyxx Pharmaceuticals to a 2008 profit, according to a Lehman Brothers analyst, who said the global opportunity for the drug has been und...READ MORE

(NEW YORK) The executive vice president and chief business officer of biopharmaceutical company Onyx Pharmaceuticals Inc. exercised options for and then sold 12,500 shares of common stock, a...READ MORE

(NEW YORK)Stocks that were moving substantially or trading heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market: NYSEREAD MORE

Among the earnings stories for Tuesday, Feb. 19, from AP Financial News: Top stories:READ MORE